HomeNewslettersHematopoiesis NewsCyclin-Dependent Kinase Inhibitor Fadraciclib (CYC065) Depletes Anti-apoptotic Protein and Synergizes with Venetoclax...
Cyclin-Dependent Kinase Inhibitor Fadraciclib (CYC065) Depletes Anti-apoptotic Protein and Synergizes with Venetoclax in Primary Chronic Lymphocytic Leukemia Cells
Researchers provide a rationale for the clinical development of fadraciclib in chronic lymphocytic leukemia, either alone or in combination with a Bcl-2 antagonist.